Market
Sour cherry powder (commonly tart cherry-derived) in the United States is positioned as a value-added fruit ingredient used in functional foods and dietary supplements. The U.S. has a large tart cherry growing and processing footprint, with commercial production concentrated in states such as Michigan and parts of the Pacific Northwest. Availability to downstream buyers is typically year-round due to processing and inventory, while quality is highly sensitive to moisture uptake and oxidation during storage and distribution. Market access risk is dominated by FDA compliance for import entry and for labeling/claims depending on whether the product is marketed as a conventional food ingredient or a dietary supplement ingredient.
Market RoleDomestic producer and consumer market (value-added tart cherry ingredient hub)
Domestic RoleIngredient supply for U.S. functional food and dietary supplement manufacturing; also sold as branded consumer powder in some channels
Market GrowthNot Mentioned
SeasonalityRaw tart cherry harvest is seasonal, but powder supply is typically managed for year-round availability through processing and storage; timing varies by producing region.
Risks
Regulatory Compliance HighNon-compliance with U.S. FDA import requirements (e.g., missing/incorrect import filings where applicable, facility registration issues, or adulteration/misbranding concerns) can result in detention, refusal, or costly delays that effectively block market access for sour cherry powder shipments.Use an FDA/CBP import-compliance checklist aligned to the product’s intended use (food vs dietary supplement), confirm facility registration status where applicable, and run pre-shipment label/claims and documentation review with the U.S. importer of record.
Food Safety MediumPowdered foods can present elevated sensitivity to contamination and cross-contact risks (and are difficult to remediate post-pack), increasing recall and customer-rejection risk if supplier preventive controls and verification testing are weak.Qualify suppliers using GFSI-aligned audits where feasible, define microbiological and chemical acceptance criteria in specifications, and require COAs with lot-level traceability.
Labeling And Claims MediumIf marketed into the U.S. as a dietary supplement ingredient or finished supplement, claims that imply disease treatment/prevention or otherwise exceed allowable structure/function positioning can trigger enforcement and retailer delisting risk.Align marketing claims to the applicable U.S. framework (food vs dietary supplement), maintain substantiation files for claims, and implement label review controls before each market release.
Logistics MediumMoisture ingress and packaging failure during long transit or warehousing can cause caking and quality deterioration (color/flavor loss), leading to rejected lots and downstream manufacturing disruptions.Specify moisture/oxygen barrier packaging, use desiccant where appropriate, validate packaging integrity, and implement receiving QC checks for caking and sensory deviation.
Standards- SQF
- BRCGS
- FSSC 22000
- USDA Organic (NOP) certification (when marketed as organic)
FAQ
What are the most common U.S. entry and compliance steps for imported sour cherry powder?U.S. imports typically require standard customs documentation (commercial invoice, packing list, and bill of lading/air waybill) and a CBP entry filing. If the shipment is treated as food, FDA Prior Notice is commonly required, and FDA may review the entry and examine/samples products for compliance. Depending on the supply chain role, FDA Food Facility Registration can also be relevant for applicable facilities.
Does U.S. regulation differ if sour cherry powder is sold as a food ingredient versus a dietary supplement ingredient?Yes. The U.S. compliance approach depends on how the product is marketed and used: conventional food ingredient use is generally managed under FDA’s food regulatory framework (including preventive controls expectations where applicable), while dietary supplement uses are subject to dietary supplement-specific requirements, including GMP expectations and tighter scrutiny of labeling and claims. Claims that imply disease treatment/prevention increase enforcement risk.